Yarrow Bioscience (YARW) EPS (Basic) (2017 - 2026)
Yarrow Bioscience's (YARW) quarterly EPS (Basic) came in at -$0.01 in Q2 2025, up 27.57% YoY from -$0.01 in Q2 2024, and little changed on a QoQ basis from -$0.01 in Q1 2025.
Yarrow Bioscience (YARW) EPS (Basic) (2017 - 2026) Analysis & Trends
Yarrow Bioscience (YARW) has 9 years of EPS (Basic) data on file, last reported at -$0.01 in Q2 2025.
- Quarterly EPS (Basic) rose 27.57% year-over-year to -$0.01 in Q2 2025, while the trailing twelve-month figure through Mar 2026 was -$0.02 (up 40.87% YoY) and the FY2025 annual result came in at $0.3, up 1033.12% from the prior year.
- EPS (Basic) held at -$0.01 in Q2 2025, from -$0.01 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $217.14 in Q1 2022 to a low of -$178.15 in Q1 2021.
- A 5-year average of -$20.56 and a median of -$0.31 in 2023 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2022 — EPS (Basic) soared 221.89% — and 2023, when it slumped 146.61%.
- Tracing YARW's EPS (Basic) over 5 years: stood at -$55.92 in 2021, then jumped by 38.7% to -$34.27 in 2022, then soared by 99.49% to -$0.18 in 2023, then surged by 94.64% to -$0.01 in 2024, then increased by 0.4% to -$0.01 in 2025.
- The last three EPS (Basic) figures came in at -$0.01 (Q2 2025), -$0.01 (Q1 2025), and -$0.01 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.90 Bn | 132.05 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 86.70 Bn | 78.71 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 65.73 Bn | 60.55 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 58.33 Bn | 53.19 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 42.16 Bn | 37.07 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.72 Bn | 28.42 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 28.27 Bn | 9.88 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.61 Bn | 26.45 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.25 Bn | 26.41 Bn | - | 0.18 |
| 10 | Yarrow Bioscience | 31.01 Mn | 8.08 Mn | - | -3.50 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.13 |
| Jun 30, 2025 | -0.01 |
| Mar 31, 2025 | -0.01 |
| Dec 31, 2024 | -0.01 |
| Jun 30, 2024 | -0.01 |
| Mar 31, 2024 | -0.01 |
| Dec 31, 2023 | -0.18 |
| Sep 30, 2023 | -7.82 |
| Jun 30, 2023 | -0.31 |
| Mar 31, 2023 | -0.15 |
| Dec 31, 2022 | -34.27 |
| Sep 30, 2022 | -3.17 |
| Jun 30, 2022 | -3.74 |
| Mar 31, 2022 | 217.14 |
| Dec 31, 2021 | -55.92 |
| Sep 30, 2021 | -121.23 |
| Jun 30, 2021 | -161.72 |
| Mar 31, 2021 | -178.15 |
| Dec 31, 2020 | -643.51 |
| Sep 30, 2020 | -530.38 |